Literature DB >> 3690054

Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages.

L E Bermudez1, L S Young.   

Abstract

1. Host defenses against Mycobacterium avium complex (MAC) are poorly defined. Peritoneal macrophages from black and beige mice, and cultured human macrophages were infected in vitro with MAC serotype 1 from an AIDS patient, in the presence or absence of normal or convalescent serum. Bacteria:cell ratio was 1:10. Supernatants and macrophage lysates were cultured 6, 24 and 48 h later to determine the uptake and killing by macrophages. Phagocytosis by activated macrophages, obtained from pre-infected and treated mice or stimulated in vitro with endotoxin, was also studied. 2. Neither convalescent serum nor normal serum caused a significant increase in MAC phagocytosis. 3. Unstimulated macrophages from black or beige mice and humans were incapable of killing the intracellular bacteria. Activated macrophages from all sources phagocytized and killed 80 +/- 4% of the initial inoculum after 48 h in culture. 4. These results demonstrate that activated macrophages are required for optimal intracellular killing of serotype 1 MAC.

Entities:  

Mesh:

Year:  1987        PMID: 3690054

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  8 in total

Review 1.  Immunobiology of Mycobacterium avium infection.

Authors:  L E Bermudez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

2.  Stimulation with cytokines enhances penetration of azithromycin into human macrophages.

Authors:  L E Bermudez; C Inderlied; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

3.  Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway.

Authors:  L E Bermudez; A Parker; J R Goodman
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.

Authors:  R T Mehta
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 5.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Differences in uptake of mycobacteria by human monocytes: a role for complement.

Authors:  R P Swartz; D Naai; C W Vogel; H Yeager
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.

Authors:  L E Bermudez; M Petrofsky; P Stevens
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

8.  Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.

Authors:  L E Bermudez; L S Young; H Enkel
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.